Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway

Mitophagy preserves microvascular structure and function during myocardial ischemia/reperfusion (I/R) injury. Empagliflozin, an anti-diabetes drug, may also protect mitochondria. We explored whether empagliflozin could reduce cardiac microvascular I/R injury by enhancing mitophagy. In mice, I/R inju...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Chen, Guo, Zhongzhou, Chang, Xing, Li, Ziying, Wu, Feng, He, Jing, Cao, Tiantian, Wang, Kangrong, Shi, Nengxian, Zhou, Hao, Toan, Sam, Muid, David, Tan, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938627/
https://www.ncbi.nlm.nih.gov/pubmed/35325804
http://dx.doi.org/10.1016/j.redox.2022.102288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938627/
https://www.ncbi.nlm.nih.gov/pubmed/35325804
http://dx.doi.org/10.1016/j.redox.2022.102288

Ejemplares similares